COMPARATIVE IN-VITRO ACTIVITY OF PIPERACILLIN TAZOBACTAM AGAINST RECENT CLINICAL ISOLATES, A DUTCH NATIONAL MULTICENTER STUDY

被引：6
作者：
STOBBERINGH, EE
MACLAREN, DM
SCHMITZ, PIM
DIRKSGO, SIS
DANKERT, J
LIGTVOET, EEJ
LICHTENDAHLBERNARDS, AT
HORREVORTS, AM
THEWESSEN, EAPM
BANFFER, JRJ
WAGENVOORT, JHT
HENDRIKS, WDH
BRIMICOMBE, RW
LIM, BT
VISSER, MR
VANKLINGEREN, B
VANKREGTEN, E
DEJONG, J
SCHREUDER, H
SABBE, LJM
WINTERMANS, RGF
DIEPERSLOOT, RJA
SONDERKAMP, HJA
VANDIJKE, BF
FABIUS, GTJ
DAVIES, BI
HOOGKAMPKORSTANJE, JAA
DEJONG, A
SEVERIN, WPJ
DEGENER, JE
MANSON, WL
VERBRUGH, H
机构：
[1] FREE UNIV AMSTERDAM HOSP,DEPT CLIN MICROBIOL & INFECT CONTROL,AMSTERDAM,NETHERLANDS
[2] DR DANIEL DEN HOED CANC CTR,DEPT TRIALS & STAT,3008 AE ROTTERDAM,NETHERLANDS
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1994年 / 34卷 / 05期
关键词：
D O I：
10.1093/jac/34.5.777
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
In this Dutch national survey piperacillin-tazobactam had a MIC(90) of less than or equal to 8 mg/L for Enterobacteriaceae (Enterobacter cloacae excluded) and Pseudomonas aeruginosa, 64 mg/L for E. cloacae, and 4 mg/L for Acinetobacter spp. The corresponding MIC(90) values for piperacillin alone were less than or equal to 256 mg/L, 256 mg/L, 16 mg/L and 32 mg/L. Only 15 of 93 piperacillin-tazobactam resistant E. cloacae strains were sensitive for ceftazidime, whereas 41 of 93 ceftazidime-resistant E. cloacae were sensitive to piperacillin-tazobactam.
引用
收藏
页码：777 / 783
页数：7
相关论文
共 50 条
[21]   In vitro interaction of voriconazole with imipenem/cilastatin and piperacillin/tazobactam against clinical Candida albicans isolates [J].
Ozcan, S. E. M. A. Keceli ;
Mutlu, B. .
MYCOSES, 2009, 52 :111-111
[22]   In vitro antibacterial activity of ertapenem in comparison with penicillin, piperacillin/tazobactam, clindamycin, and metronidazole against clinical isolates of anaerobic bacteria [J].
Pfister, W ;
Roedel, J ;
Weisser, H ;
Straube, E .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 :147-147
[23]   ACTIVITY IN-VITRO OF MEROPENEM AGAINST CLINICAL ISOLATES [J].
ZANETTI, S ;
JULIANO, C ;
SECHI, L ;
ANGIOI, A ;
GAVINI, E ;
PIRINA, P ;
FADDA, G .
JOURNAL OF CHEMOTHERAPY, 1993, 5 :121-122
[24]   IN-VITRO EXTRACELLULAR AND INTRACELLULAR ACTIVITIES OF CLAVULANIC ACID AND THOSE OF PIPERACILLIN AND CEFTRIAXONE ALONE AND IN COMBINATION WITH TAZOBACTAM AGAINST CLINICAL ISOLATES OF LEGIONELLA SPECIES [J].
EDELSTEIN, PH ;
EDELSTEIN, MAC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :200-204
[25]   INVITRO ACTIVITY OF CEFEPIME, A NEW PARENTERAL CEPHALOSPORIN, AGAINST RECENT EUROPEAN BLOOD ISOLATES AND IN COMPARISON WITH PIPERACILLIN TAZOBACTAM [J].
DORNBUSCH, K ;
MORTSELL, E ;
GORANSSON, E .
CHEMOTHERAPY, 1990, 36 (04) :259-267
[26]   PIPERACILLIN TAZOBACTAM (YTR-830) COMBINATION - COMPARATIVE ANTIMICROBIAL ACTIVITY AGAINST 5889 RECENT AEROBIC CLINICAL ISOLATES AND 60 BACTEROIDES-FRAGILIS GROUP STRAINS [J].
JONES, RN ;
PFALLER, MA ;
FUCHS, PC ;
ALDRIDGE, K ;
ALLEN, SD ;
GERLACH, EH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (06) :489-494
[27]   Superior in vitro activity of ertapenem and piperacillin/tazobactam against recent clinical isolates of Proteus mirabilis from intra-abdominal infections (SMART 2009-2010) [J].
Hawser, Stephen P. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (02) :186-187
[28]   NATIONAL SURVEY OF THE IN-VITRO SPECTRUM OF PIPERACILLIN-TAZOBACTAM TESTED AGAINST MORE THAN 40,000 AEROBIC CLINICAL ISOLATES FROM 236 MEDICAL-CENTERS [J].
BARON, EJ ;
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (03) :141-151
[29]   COMPARATIVE IN-VITRO ACTIVITY OF FLEROXACIN AGAINST 480 NOSOCOMIAL ISOLATES [J].
SOFIANOU, D ;
FRANTZIDOU, F ;
TSAKRIS, A .
JOURNAL OF CHEMOTHERAPY, 1994, 6 (06) :399-403
[30]   In Vitro Activity of Piperacillin/Tazobactam against Pseudomonas Species in Paediatric Population [J].
Mannan, Talha ;
Zafar, Aizza ;
Mehdi, Naima .
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (04) :1143-1146
12345